Trial Profile
An investigator initiated trial of rucaparib in gastroesophageal cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Nov 2016
Price :
$35
*
At a glance
- Drugs Rucaparib (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- Acronyms PLATFORM
- 16 Nov 2016 New trial record